Evidence map›Paper›PMID 31316733›Full record

ReviewIranian journal of neurology2019

Historical perspective of neurology in Iran.

Shri Kant Mishra, Hadi Mohammad Khanli, Golnoush Akhlaghipour, Ghazaleh Ahmadi Jazi, Shaweta Khosa

Abstract readReview
In one paragraph

Review in Iranian journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shri Kant MishraDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United States.
Hadi Mohammad KhanliDepartment of Neurology, George Washington School of Health and Medical Sciences, Washington, DC, United States.
Golnoush AkhlaghipourDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United States.
Ghazaleh Ahmadi JaziDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United States.
Shaweta KhosaDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iran is an ancient country, known as the cradle of civilization. The history of medicine in Iran goes back to the existence of a human in this country, divided into three periods: pre-Islamic, medieval, and modern period. There are records of different neurologic terms from the early period, while Zoroastrian (religious) prescription was mainly used until the foundation of the first medical center (Gondishapur). In the medieval period, with the conquest of Islam, prominent scientists were taught in Baghdad, like Avicenna, who referred to different neurologic diseases including stroke, paralysis, tremor, and meningitis. Several outstanding scientists developed the medical science of neurology in Iran, the work of whom has been used by other countries in the past and present. In the modern era, the Iranian Neurological Association was established with the efforts of Professor Jalal Barimani in 1991.

Indexed as

HistoryIranMedicineNeurology

Identifiers

PMID31316733
PMCPMC6626609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.